HERE vs POM
Here Group Ltd. and Pomdoctor Ltd., side by side — 2 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | HERE | POM |
|---|---|---|
| Revenue | CNY 2.7B | CNY 399.9M |
| Net income | CNY 358.7M | CNY -130.9M |
| Gross margin | 81.5% | · |
| Net margin | 13.1% | · |
| Return on equity | 54.1% | · |
| Diluted EPS | CNY 2.17 | −CNY 21.96 |
| Dividend / share | · | · |
| Payout ratio | 21.8% | · |
| Free cash flow | CNY 180.8M | CNY -149.5M |
| Equity | CNY 809.0M | CNY -454.0M |
| Net debt / equity | −1.01× | · |
| Current ratio | 2.14× | 0.48× |
| Revenue CAGR 5y | · | · |
| Profit CAGR 5y | · | · |
HERE bills 6.8× the revenue of POM, and POM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
Revenue by year
2 years side by side
| Fiscal year | HERE | POM |
|---|---|---|
| FY2024 | CNY 2.7B | CNY 342.6M |
| FY2023 | CNY 3.8B | CNY 304.9M |
Net income by year
Bottom line
| Fiscal year | HERE | POM |
|---|---|---|
| FY2024 | CNY 358.7M | CNY -37.4M |
| FY2023 | CNY 385.5M | CNY -36.9M |
More in this industry